THE PHARMACOLOGICAL BASIS FOR THE USE OF ALPHA-1-ADRENOCEPTOR ANTAGONISTS IN THE TREATMENT OF ESSENTIAL-HYPERTENSION

被引：6

作者：

DAVEY, MJ

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷

关键词：

D O I：

10.1111/j.1365-2125.1986.tb02847.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S5 / S8

页数：4

共 24 条

[1] PRAZOSIN IN TREATMENT OF PATIENTS WITH HYPERTENSION AND RENAL FUNCTIONAL IMPAIRMENT [J].

BAILEY, RR .

MEDICAL JOURNAL OF AUSTRALIA, 1977, 2 :42-45

[2] METABOLIC EFFECTS OF PRAZOSIN [J].

BARBIERI, C ;

CALDARA, R ;

FERRARI, C ;

DALBO, GA ;

PARACCHI, A ;

ROMUSSI, M ;

CURTARELLI, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :313-316

[3] METABOLIC EFFECTS OF CHRONIC PRAZOSIN TREATMENT [J].

BARBIERI, C ;

FERRARI, C ;

BORZIO, M ;

PIEPOLI, V ;

CALDARA, R .

HORMONE AND METABOLIC RESEARCH, 1980, 12 (07) :331-334

[4] PRAZOSIN - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HYPERTENSION [J].

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1977, 14 (03) :163-197

[5]

CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, P514

[6] ALPHA-ADRENERGIC RECEPTOR BLOCKADE WITH PRAZOSIN - CONSIDERATION OF HYPERTENSION, HEART-FAILURE, AND POTENTIAL NEW APPLICATIONS [J].

COLUCCI, WS .

ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) :67-77

[7] NEUROGENIC FACTORS IN HUMAN HYPERTENSION - MECHANISM OR MYTH [J].

DEQUATTRO, V ;

MIURA, Y .

AMERICAN JOURNAL OF MEDICINE, 1973, 55 (03) :362-378

[8]

HEAGERTY AM, 1982, BRIT J CLIN PHARMACO, V13, P539

[9] NEW APPROACHES TO THE THERAPY OF MILD HYPERTENSION [J].

KAPLAN, NM .

AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (04) :621-627

[10] PRAZOSIN AND CLONIDINE FOR MODERATELY SEVERE HYPERTENSION [J].

KIRKENDALL, WM ;

HAMMOND, JJ ;

THOMAS, JC ;

OVERTURF, ML ;

ZAMA, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (23) :2553-2556

← 1 2 3 →